NEWS

Asia Regenerative Medicine Successfully Closes First Tranche of Series A Funding to Advance Clinical Translation of Kidney Cell and Device Products

October 30, 2025 | AEF | Portfolio
Share :
此文章只有中文版本

Prev
Next
Recent Posts
—
January 15, 2026
GEB -101 Receives U.S. FDA IND Clearance
January 5, 2026
Aitrasound Medical Group to Be Named “SME of the Year” at the SCMP Business Awards 2025
December 15, 2025